Literature DB >> 18264770

Comparative analysis of the expression of c-Fos and interleukin-2 proteins in hypothalamus cells during various treatments.

S V Barabanova1, Z E Artyukhina, K T Ovchinnikova, T V Abramova, T B Kazakova, V Kh Khavinson, V V Malinin, E A Korneva.   

Abstract

The aim of the present work was to perform a combined analysis of the degree of activation of the anterior hypothalamus of the rat and expression of the interleukin-2 gene during treatments of different types: mild stress ("handling") and adaption to it, as well as intranasal administration of physiological saline and the peptides Vilon (Lys-Glu) and Epitalon (Ala-Glu-Asp-Gly). Changes in the numbers of c-Fos-and IL-2-positive cells in structures of the lateral area (LHA) and anterior (AHN), supraoptic (SON), and paraventricular (PVN) nuclei of the hypothalamus in Wistar rats. Ratios of the quantities of c-Fos-and IL-2-positive cells were determined in intact animals and after activation of brain cells initiated by different treatments; the influences of adaptation to handling on the nature of changes in the expression of these proteins was also studied. Combined analysis of the intensity of expression of these two proteins - c-Fos, a marker of neuron activation and a trans-factor for the IL-2 cytokine gene and other inducible genes, and IL-2 - in intact animals and after various treatments showed that the process of cell activation in most of the hypothalamic structures studied correlated with decreases in the quantity of IL-2-positive cells in these structures; different patterns of changes in the numbers of c-Fos-and IL-2-positive cells were seen in response to different treatments in conditions of stress and adaptation to it.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264770     DOI: 10.1007/s11055-008-0035-x

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  34 in total

1.  Synthesis of IL-2 mRNA in cells of rat hypothalamic structures after injection of short peptides.

Authors:  T B Kazakova; S V Barabanova; N S Novikova; M S Glushikhina; V Kh Khavinson; V V Malinin; E A Korneva
Journal:  Bull Exp Biol Med       Date:  2005-06       Impact factor: 0.804

2.  Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus.

Authors:  S Karanth; K Lyson; S M McCann
Journal:  Neuroimmunomodulation       Date:  1999 May-Jun       Impact factor: 2.492

3.  Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.

Authors:  L Capuron; A Ravaud; R Dantzer
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

4.  Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients.

Authors:  L Capuron; A Ravaud; R Dantzer
Journal:  Psychosom Med       Date:  2001 May-Jun       Impact factor: 4.312

5.  Phasic hyperactivity of the HPA axis resulting from chronic central IL-2 administration.

Authors:  U K Hanisch; W Rowe; D van Rossum; M J Meaney; R Quirion
Journal:  Neuroreport       Date:  1996-11-25       Impact factor: 1.837

6.  Interleukin-2 inhibits the GABA-induced Cl- current in identified Aplysia neurons.

Authors:  M Sawada; N Hara; M Ichinose
Journal:  J Neurosci Res       Date:  1992-11       Impact factor: 4.164

7.  In vivo modulation of myelin gene expression by human recombinant IL-2.

Authors:  M Sessa; R Nemni; S Iannaccone; A Quattrini; V Confalonieri; N Canal
Journal:  Brain Res Mol Brain Res       Date:  1992-02

8.  Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2.

Authors:  U K Hanisch; D Seto; R Quirion
Journal:  J Neurosci       Date:  1993-08       Impact factor: 6.167

9.  Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system.

Authors:  D M Araujo; P A Lapchak; B Collier; R Quirion
Journal:  Brain Res       Date:  1989-10-02       Impact factor: 3.252

10.  IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling.

Authors:  J Raber; F E Bloom
Journal:  J Neurosci       Date:  1994-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.